Vision Scientists And FDA Discuss Endpoint Measures For Assessing Glaucoma Therapies
The vision research community is discussing with the Food and Drug Administration (FDA) how to adopt and/or implement safe and effective endpoint measures for assessing glaucoma therapies in U.S. clinical trials...